This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire D'angers, Centre Hospitalier Universitaire De Bordeaux, Centre National De La Recherche Scientifique. Active years: 2025.
Company Filing History:
1 out of 14 
1 out of 25 
1 out of 5,383 
Years Active: 2025
Title: Cecile Contin-Bordes: Innovator in Thrombotic Microangiopathies Treatment
Introduction
Cecile Contin-Bordes is a notable inventor based in Mérignac, France. He has made significant contributions to the field of medicine, particularly in the treatment of thrombotic microangiopathies (TMA). His innovative work has led to the development of a unique pharmaceutical composition that utilizes clusterin for therapeutic purposes.
Latest Patents
Cecile Contin-Bordes holds 1 patent for his invention titled "Clusterin for use in the treatment of thrombotic microangiopathies." This patent outlines a pharmaceutical composition comprising clusterin, specifically designed for treating TMA. The invention also includes an ex vivo method for stratifying patients likely to benefit from clusterin treatment, based on the measurement of clusterin levels in biological samples.
Career Highlights
Throughout his career, Cecile has worked with esteemed institutions such as Université de Bordeaux and Centre Hospitalier Universitaire de Bordeaux. His research and innovations have garnered attention in the medical community, particularly for their potential impact on patient care in thrombotic conditions.
Collaborations
Cecile has collaborated with notable colleagues, including Yahsou Delmas and Patrick Blanco. Their combined expertise has contributed to advancing research in the field of thrombotic microangiopathies.
Conclusion
Cecile Contin-Bordes is a pioneering inventor whose work in the treatment of thrombotic microangiopathies showcases the importance of innovation in medicine. His contributions are poised to make a significant difference in patient outcomes.